U.S., Poland Agree to Exchange GMP Inspection Results

The U.S. Food and Drug Administration and Poland’s Główny Inspektorat Farmaceutyczny have agreed to share the results of good manufacturing practice inspections, building on a practice increasingly embraced by regulators around the world.
International Pharmaceutical Regulatory Monitor